These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 11929828

  • 1. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ.
    Cancer Res; 2002 Apr 01; 62(7):2077-84. PubMed ID: 11929828
    [Abstract] [Full Text] [Related]

  • 2. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.
    Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Barrington RE, Windle JJ.
    Cancer Res; 1997 Feb 15; 57(4):600-3. PubMed ID: 9044833
    [Abstract] [Full Text] [Related]

  • 3. Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer model.
    Jones JM, Cui XS, Medina D, Donehower LA.
    Cell Growth Differ; 1999 Apr 15; 10(4):213-22. PubMed ID: 10319991
    [Abstract] [Full Text] [Related]

  • 4. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model.
    Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ, Sebti SM.
    Oncogene; 2000 Nov 09; 19(47):5338-47. PubMed ID: 11103935
    [Abstract] [Full Text] [Related]

  • 5. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB.
    Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672
    [Abstract] [Full Text] [Related]

  • 6. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A, Deng C, Campos-Torres J, Donehower LA, Leder P.
    Oncogene; 1995 Jul 06; 11(1):181-90. PubMed ID: 7624126
    [Abstract] [Full Text] [Related]

  • 7. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
    Jackson RJ, Adnane J, Coppola D, Cantor A, Sebti SM, Pledger WJ.
    Oncogene; 2002 Dec 05; 21(55):8486-97. PubMed ID: 12466968
    [Abstract] [Full Text] [Related]

  • 8. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ.
    Cancer Res; 2001 Apr 15; 61(8):3373-81. PubMed ID: 11309295
    [Abstract] [Full Text] [Related]

  • 9. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

  • 10. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B.
    Cancer Res; 2007 Apr 01; 67(7):3135-44. PubMed ID: 17409420
    [Abstract] [Full Text] [Related]

  • 11. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A, Salazar E, Sun TT, Wu XR, Pellicer A.
    Cancer Res; 2005 Feb 15; 65(4):1150-7. PubMed ID: 15734997
    [Abstract] [Full Text] [Related]

  • 13. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
    Peschiaroli A, Figliola R, Coltella L, Strom A, Valentini A, D'Agnano I, Maione R.
    Oncogene; 2002 Nov 21; 21(53):8114-27. PubMed ID: 12444547
    [Abstract] [Full Text] [Related]

  • 14. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice.
    Martín-Caballero J, Flores JM, García-Palencia P, Serrano M.
    Cancer Res; 2001 Aug 15; 61(16):6234-8. PubMed ID: 11507077
    [Abstract] [Full Text] [Related]

  • 15. [Changes in the activity of cyclin-kinase complexes governing cell transition from G1 phase to DNA replication phase in E1A + c-Ha-ras transformants transfected with the bcl-2 gene].
    Neliudova AM, Aksenov ND, Pospelova TV.
    Tsitologiia; 2003 Aug 15; 45(2):149-57. PubMed ID: 12722479
    [Abstract] [Full Text] [Related]

  • 16. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T, Fukushima S.
    Cancer Res; 1997 Nov 01; 57(21):4765-76. PubMed ID: 9354438
    [Abstract] [Full Text] [Related]

  • 17. Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1.
    Hermeking H, Funk JO, Reichert M, Ellwart JW, Eick D.
    Oncogene; 1995 Oct 05; 11(7):1409-15. PubMed ID: 7478565
    [Abstract] [Full Text] [Related]

  • 18. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
    Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV.
    Nature; 1994 Jun 23; 369(6482):669-71. PubMed ID: 8208295
    [Abstract] [Full Text] [Related]

  • 19. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells.
    Liberto M, Cobrinik D, Minden A.
    Oncogene; 2002 Feb 28; 21(10):1590-9. PubMed ID: 11896588
    [Abstract] [Full Text] [Related]

  • 20. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M.
    J Exp Clin Cancer Res; 2005 Sep 28; 24(3):405-14. PubMed ID: 16270527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.